Microsoft, Novartis Partner in Developing a System to Assess Multiple Sclerosis

Multiple Sclerosis

Microsoft Corporation (NASDAQ:MSFT) and Novartis (NYSE:NVS) partnered to develop a system that would precisely measure the symptoms of multiple sclerosis. The system could potentially allow the development of better, cheaper and faster treatments for patients. The researchers of Microsoft and Novartis are working on a project called Assess MS. The project utilizes the tech giant’s Kinect motion camera, machine learning software to track movements to analyze a patient’s movement from a step to his/her ability to touch one’s nose with a finger. Novartis has been trying to find a more…

Read More